Companies Attending the 10th Anniversary Include: Madrigal Pharmaceuticals, Arda Therapeutics, Tribune Therapeutics, AbbVie, aTyr Pharma, Pfizer and lots more - View the Full Event Guide Breakdown

United Therapeutics Moves Toward the First Inhaled Antifibrotic for IPF

Insilico Medicine's rentosertib (INS018_055) has entered Phase III development for IPF

Skye Bioscience and Redx Pharma announced plans to form fibrosis-focused Fibrx Therapeutics

Global interest continues to surge following Eli Lilly's $630 million licensing deal with OliX Pharmaceuticals for the MASH/obesity cross-indication asset OLX702A

Yuhan Develops Anti-Fibrosis Drug Candidate, Wins U.S. Patent

Alloy Accelerates Mediar Timeline to the Clinic for Complex Fibrosis Targets

Day

Hour

Minute

Second

Thank You for Downloading

Thank You for Completing the Form

Please click the 'download' button below to open the brochure in a new tab.

Download

Thank You for Downloading

Thank You for Completing the Form

Venue

Map

Contact

Join Our Team

About Us

Explore Our Conferences

Stay Connected

Search

Organized By